US President Donald Trump on Thursday announced a 100% tariff on imported branded and patented pharmaceutical drugs, requiring companies to have US-based manufacturing plants to avoid the duty.
“I’m putting a 100% import tax on pharmaceutical drugs unless the companies are building plants right here in the United States,” Trump said on Truth Social . “Breaking ground, under construction, that’s the deal. No exceptions."
The announcement is part of Trump’s broader strategy to strengthen domestic manufacturing in the US and reduce reliance on foreign companies.
While the policy directly targets branded drugs, it has triggered concern around the world, especially in India, which is one of the largest exporters of pharmaceuticals globally.
WHAT IT MEANS FOR INDIA
India exports over one-